US: Denmark-based life sciences investment company Novo Holdings says that it has invested US$65m in bio-based clinker-free cement producer Biomason. Biomason uses microorganisms to grow its Biocement cement, without heating or CO2 emissions. The producer is in its Series C round of financing. Novo Holdings previously invested in its Series B financing round.

Novo Holdings invests US$65m in Biomason
Written by Global Cement Staff
Published in
Global Cement News
Register for the Global Cement Weekly email newsletter
Global Cement Weekly is Global Cement’s weekly email newsletter. Keep up to date with cement industry news, analysis, diary dates and news of people in the sector.